CCL18 and neoplasm: In opposition to gastric cancer, CCL18 could promote the tumor malignant progression of breast cancer [10], ovarian cancer [12], bladder cancer [13], pancreatic cancer [14], and skin diseases [15], and its upregulation could predict poor prognosis in these cancers.